BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17026569)

  • 1. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
    Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
    Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforated peptic ulcer: use of pre-admission oral glucocorticoids and 30-day mortality.
    Christensen S; Riis A; Nørgaard M; Thomsen RW; Tønnesen EM; Larsson A; Sørensen HT
    Aliment Pharmacol Ther; 2006 Jan; 23(1):45-52. PubMed ID: 16393279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drugs and short-term mortality after peptic ulcer perforation: a population-based cohort study.
    Christiansen C; Christensen S; Riis A; Thomsen RW; Johnsen SP; Tonnesen E; Sorensen HT
    Aliment Pharmacol Ther; 2008 Oct; 28(7):895-902. PubMed ID: 18637098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
    Patterson MK; Castellsague J; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
    Christensen S; Riis A; Nørgaard M; Thomsen RW; Sørensen HT
    Aliment Pharmacol Ther; 2007 Apr; 25(8):907-12. PubMed ID: 17402994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preadmission use of systemic glucocorticoids and 30-day mortality following bleeding peptic ulcer: a population-based cohort study.
    Olsen M; Christensen S; Riis A; Thomsen RW
    Am J Ther; 2010; 17(1):23-9. PubMed ID: 19531935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
    Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term mortality after perforated or bleeding peptic ulcer among elderly patients: a population-based cohort study.
    Christensen S; Riis A; Nørgaard M; Sørensen HT; Thomsen RW
    BMC Geriatr; 2007 Apr; 7():8. PubMed ID: 17439661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforated peptic ulcer and short-term mortality among tramadol users.
    Tørring ML; Riis A; Christensen S; Thomsen RW; Jepsen P; Søndergaard J; Sørensen HT
    Br J Clin Pharmacol; 2008 Apr; 65(4):565-72. PubMed ID: 17922882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
    Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
    BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
    van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
    Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
    Mose H; Larsen M; Riis A; Johnsen SP; Thomsen RW; Sørensen HT
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):244-50. PubMed ID: 17062325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.